Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 5/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | APAF1 | O14727 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21606317 | 0.94 | TSHR (0.46) | CHRM1CHRM3CHRM2CHRM4LMNA | |
| SCHEMBL21606316 | 0.89 | TSHR (0.47) | TDP1LMNATSHRALDH1A1CYP3A4 | |
| SCHEMBL21605318 | 0.88 | PIN1 (0.46) | TDP1LMNATSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL21606286 | 0.87 | TSHR (0.50) | LMNATSHRALDH1A1CYP3A4SMN1; SMN2 | |
| SCHEMBL21606341 | 0.84 | GAA (0.40) | TDP1CYP2D6ALDH1A1 | |
| SCHEMBL21605322 | 0.84 | HIF1A (0.33) | CHRM1CHRM3CHRM2TDP1APAF1 | |
| SCHEMBL21606343 | 0.82 | AAK1 (0.40) | TDP1APAF1ALDH1A1 | |
| SCHEMBL21606279 | 0.82 | APAF1 (0.44) | APAF1CYP1A2CYP2D6TSHRALDH1A1 | |
| SCHEMBL21605326 | 0.76 | CYP19A1 (0.46) | CHRM1CHRM3CHRM2CHRM4LMNA | |
| SCHEMBL9408891 | 0.72 | GAA (0.53) | LMNACYP1A2CYP2D6TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3810619-B1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES | CLARIANT INT LTD (CH) | 2023-04-26 | — | — | EP | disclosed |
| US-20210159432-A1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES | CLARIANT INTERNATIONAL LTD (CH) | 2021-05-27 | — | — | US | disclosed |
| WO-2019243580-A1 | PHENYLPHOSPHINO COMPOUNDS AS PROCESS STABILIZERS | CLARIANT PLASTICS & COATINGS LTD (CH) | 2019-12-26 | — | — | WO | disclosed |
| WO-2019243583-A1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES | CLARIANT PLASTICS & COATINGS LTD (CH) | 2019-12-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210159432-A1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES | NPY1R, TAAR1, CHRNA1 | CHRM1 5/4885CHRM3 78/4885CHRM2 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.